Incretin Mimetics Market Size to Surpass $38.01 Billion by 2034 Amid AI-Powered Drug Discovery and Diabetes Innovation
HealthcareSurging Diabetes Prevalence and Technological Breakthroughs Propel Market to 5.07% CAGR Through 2034 The global incretin mimetics market is undergoing rapid transformation, on track to surge from $24.36 billion in 2025 to approximately $38.01 billion by 2034, a robust CAGR of 5.07%. With diabetes and obesity rates rising worldwide, advancements in GLP-1 analogs and AI-powered […]